We provide comprehensive information about coronary heart disease, including risk factors, symptoms, diagnosis and treatment options. We also offer advice on science-based nutrition, exercise and stress management for a heart-healthy life.
AstraZeneca has announced a deal worth up to $1.9 billion to license a new cardiovascular medication from CSPC Pharmaceutical Group. The agreement includes an upfront payment of $100 million, with …